Related Experiment Video
Updated: Jun 20, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Methotrexate information booklet study 2008.
A Mohammad1, A Kilcoyne, U Bond
1Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland. ausafmohammad@gmail.com
Clinical and Experimental Rheumatology
|September 24, 2009
Summary
The methotrexate information booklet significantly improved patient understanding of treatment, folic acid, and monitoring. Patients receiving the booklet demonstrated better knowledge of medication, side effects, and necessary precautions.
Area of Science:
- Rheumatology
- Patient Education
- Clinical Trials
Background:
- Assessing the efficacy of patient education materials is crucial in rheumatology.
- Methotrexate (MTX) is a common medication requiring patient comprehension for optimal adherence and safety.
Purpose of the Study:
- To evaluate the impact of a methotrexate information booklet on patient understanding.
- To compare knowledge levels between patients receiving standard care versus those with an educational intervention.
Main Methods:
- A single-blind, prospective controlled trial was conducted with patients in two rheumatology services.
- Participants were divided into an active arm (n=40) using the MTX booklet and a control arm (n=38) without it.
- Patient interviews were conducted over six months using a standardized MTX questionnaire.
Main Results:
- 100% of the active-arm patients understood why they were taking folic acid, compared to 26% in the control arm.
- 88% in the active arm understood the necessity of monthly blood tests versus 47% in the control arm.
- Active-arm patients showed significantly higher awareness of contraception needs (100% vs. 60%) and MTX side effects (100% vs. 40%) compared to controls.
Conclusions:
- The methotrexate information booklet effectively enhanced patient comprehension of their treatment.
- Educational interventions are valuable tools for improving patient knowledge in rheumatology settings.
- Improved patient understanding can lead to better treatment adherence and outcomes.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...